WASHINGTON The U.S. government's costs could increase by $2.3 billion in 2018 if Congress and President Donald Trump decide not to fund Obamacare-related payments to health insurers, according to a study released Tuesday by the Kaiser Family Foundation.
- White House says vote on healthcare plan may not come for weeks
- NASH: The next untapped pharma market gives investors many options |
- Mindfulness-based stress reduction only slightly improves low back pain
- Poorest preschoolers most vulnerable to fatal child abuse
- Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen
(Reuters Health) - Adults who don't have an increased risk of hepatitis C infection should not be tested for it, the Canadian Task Force on Preventive Health Care recommended today.
(Reuters Health) - Consuming too much choline, a nutrient sold in over-the-counter dietary supplements, can boost the risk for blood clots, researchers warn.
(Reuters Health) - Death of a sibling in childhood is associated with a greater risk of early death in the surviving brother or sister, researchers say.
Eli Lilly and Co said the combination of its experimental breast cancer drug and a commonly used treatment met the main goal of a late-stage study in an interim analysis, setting the stage for a regulatory submission later this year.